Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Avecris is a Biotechnology Research brand in Singapore. Ownership is privately held; it publishes at avecris.com. It holds one address on record, all in Singapore. The record counts 6 people. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Grant, US$5.0K. It is listed alongside seven similar brands, mostly in Biotechnology Research.
UEN201735118Z
| AVECRIS PTE. LTD. | UEN 201735118Z |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
At Avecris, we are developing an innovative genetic vector platform technology that will enable a new class of medicines. Our technology is:
Universally programmable Scalable Redosable Non-integrating Cell-type specific Low cost
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 2 |
|---|---|
| Axis | 2022 to 2026 |
| Grant · 10 Sep 2022 | US$ 5.0K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. AVECRIS PTE. LTD. (UEN 201735118Z), high confidence.
The record holds 6 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Singapore only. Primary: Singapore.
Two rounds. Latest 10 September 2022: grant, US$5,000, investor First Flight Venture Center.
4 profiles list Avecris as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. Ananda Immunotherapies and DotBio list it back.